ADC Therapeutics SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADCT New York 2836 www.adctherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADC Therapeutics SA

Analysts Are Upgrading ADC Therapeutics SA (NYSE:ADCT) After Its Latest Results - May 17th, 2025 12:56 pm
ADC Therapeutics ends development of ADCT-602 and unveils latest Zynlonta data - May 15th, 2025 11:49 am
ADC Therapeutics to Present at Upcoming Investor Conferences - May 15th, 2025 11:15 am
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates - May 14th, 2025 1:10 pm
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - May 14th, 2025 12:00 pm
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML) - May 14th, 2025 11:45 am
Zymeworks Inc. (ZYME) Reports Q1 Loss, Tops Revenue Estimates - May 8th, 2025 9:50 pm
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025 - May 8th, 2025 11:15 am
Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates - May 1st, 2025 9:25 pm
AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates - Apr 30th, 2025 12:15 pm
Agenus (AGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Apr 29th, 2025 2:01 pm
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Apr 28th, 2025 2:00 pm
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025 - Apr 28th, 2025 11:00 am
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - Apr 1st, 2025 8:05 pm
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - Apr 1st, 2025 11:15 am
ADC Therapeutics SA (ADCT) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... - Apr 1st, 2025 1:00 am
ADC Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Mar 28th, 2025 11:11 am
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates - Mar 27th, 2025 12:35 pm
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update - Mar 27th, 2025 11:30 am
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 - Mar 25th, 2025 9:30 pm